Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B. Nagura Y, Matsuura K, Iio E, Fujita K, et al. PLoS One 2022;17:e0263844.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nagura Y, Matsuura K, Iio E, Fujita K, et al. Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B. PLoS One 2022;17:e0263844.
PMID: 35157730